72579-0121 TEVIMBRA - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

72579-0121

Brand Name:

TEVIMBRA

Generic Name:

Tislelizumab

Tislelizumab-jsgr

Dosage Form Name:

INJECTION, SOLUTION, CONCENTRATE

Administration Route:

Intravenous

Substances:

Name: TISLELIZUMAB

Strength: 10.0

Unit: mg/mL

Packages:

Code: 72579-0121-01

Description: 1 VIAL, GLASS in 1 CARTON (72579-121-01) / 10 mL in 1 VIAL, GLASS

Effective Date: March 14, 2024

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Checkpoint Inhibitor

Minor Class:

PD-1

Orphan Drug Designation:

Yes

Status:

In Use